# Surefire Precision Infusion System Registry

> **NCT02967523** · — · TERMINATED · sponsor: **Surefire Medical, Inc.** · enrollment: 111 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** DEB-TACE with Surefire Precision Infusion System

## Key facts

- **NCT ID:** NCT02967523
- **Lead sponsor:** Surefire Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2018-06-18
- **Final completion:** 2018-06-18
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2018-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967523, "Surefire Precision Infusion System Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02967523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*